Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

Researchers also found that about one-third of teens undergoing weight-loss surgery had a body mass index (BMI) of more than ...

A woman who lost 55 pounds on Ozempic opens up about the most difficult side effect she faced—and shares simple tips that ...

Cuban annual raw sugar production will fall below 200,000 metric tons in 2025 for the first time since the 19th century, ...

Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...

Weight-loss jabs have been hailed as the key to longer life even if you are not overweight, according to experts.

Studies have shown that GLP-1s reduce inflammation in the brain and regulate anxiety as well as depression. When insurance ...

In addition to requests for double-digit premium increases, Blue Cross Blue Shield of Vermont is also cutting back on coverage of popular weight-loss drugs on some plans.

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

Trump is benefiting from the medical infrastructure the government has built up, while simultaneously destroying that infrastructure for everyone else.

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.